rcca-header
Clinical Trials

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma

Type of Cancer
Skin and Soft Tissue
Site
Hackensack
Sponsor
SWOG
Protocol Number
SWOG S1404
To Learn More Call
(201)-510-0950